Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Motahareh Arjomandnejad, Ishani Dasgupta, Terence R. Flotte, et al.
BioDrugs (2023) Vol. 37, Iss. 3, pp. 311-329
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
Arun Srivastava
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 949-959
Open Access | Times Cited: 45
Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches
Xiaofang Li, Jintao Xu, Shanshan Yao, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders
Rrita Daci, Terence R. Flotte
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1050-1050
Open Access | Times Cited: 15
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function
Lauren V. C. Miller, Guido Papa, Marina Vaysburd, et al.
Cell (2024)
Open Access | Times Cited: 14
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
Artyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2112-2193
Closed Access | Times Cited: 12
Characterisation of the ocular inflammatory response to AAV reveals divergence by sex and age
Alison J. Clare, P. H. Langer, Amy Ward, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1246-1263
Open Access | Times Cited: 1
Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy
Ryan Purdy, Molly John, AE Bray, et al.
Progress in Retinal and Eye Research (2025), pp. 101354-101354
Open Access | Times Cited: 1
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
The roles of Th cells in myocardial infarction
Jun Liu, Feila Liu, Tingting Liang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy
Craig M. Zaidman, Natalie L. Goedeker, Amal Aqul, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 3, pp. 687-699
Open Access | Times Cited: 7
Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases
Carleigh Sussman, Rachel A. Liberatore, M. Dróżdż
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 535-535
Open Access | Times Cited: 6
Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy
Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 6, pp. 1212-1232
Open Access | Times Cited: 6
Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?
Ashley L. Harkins, Prajakta P Ambegaokar, Allison M. Keeler
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00435-e00435
Open Access | Times Cited: 6
Complement System Response to Adeno-Associated Virus Vector Gene Therapy
Elizabeth Kropf, David M. Markusic, Anna Majowicz, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 13-14, pp. 425-438
Open Access | Times Cited: 5
The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice
Anna M. Pfaller, Lew Kaplan, Madalena Carido, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
The science and practice of current environmental risk assessment for gene therapy: a review
Frank Liu
Cytotherapy (2024) Vol. 26, Iss. 7, pp. 686-699
Closed Access | Times Cited: 5
Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives
Nikita Chernyi, Darina Gavrilova, Mane Saruhanyan, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 854-854
Open Access | Times Cited: 5
Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Roni Hahn, Karen B. Avraham
Audiology Research (2023) Vol. 13, Iss. 6, pp. 952-966
Open Access | Times Cited: 12
Targeted treatment of chondrosarcoma with a bacteriophage-based particle delivering a secreted tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Aitthiphon Chongchai, Kaoutar Bentayebi, Grace Chu, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200805-200805
Open Access | Times Cited: 4
Highly branched poly β-amino ester/CpG-depleted CFTR plasmid nanoparticles for non-viral gene therapy in lung cystic fibrosis disease
Bei Qiu, Darío Manzanares, Yinghao Li, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101292-101292
Open Access | Times Cited: 4
Application of hydrogels for targeting cancer stem cells in cancer treatment
Fashun Li, Zhipeng Li, Chen Wei, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117486-117486
Open Access | Times Cited: 4
Delivery of genome editors with engineered virus-like particles
Ping Lu, Yuanhang Li, Jeffrey L. Cummings, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2025), pp. 475-516
Closed Access
State of the art in CAR-based therapy: In vivo CAR production as a revolution in cell-based cancer treatment
Abdolreza Esmaeilzadeh, Kaveh Hadiloo, Sara Yaghoubi, et al.
Cellular Oncology (2025)
Open Access
DNA Contamination Within Recombinant Adeno Associated Virus (AAV) Preparations Correlates with Decreased CD34+ Cell Clonogenic Potential
Christopher R. Luthers, Sung-Min Ha, Annika Mittelhauser, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101334-101334
Open Access | Times Cited: 3
Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids
Manthan N. Patel, Sachchidanand Tiwari, Yufei Wang, et al.
Nature Biotechnology (2025)
Closed Access
Page 1 - Next Page

Scroll to top